ARCHIVES

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

This article is from The Cancer Letter archive.

Vol. 02 No. 09 | February 27, 1976

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

In Brief: Sandor Eckhardt Is New UICC President; New Delhi Is Site Of 1994 UICC Meeting

August 31, 1990

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

Subgroup Agrees Five Compounds Are Carcinogens

January 20, 1978

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991